Journal of Intellectual Property Studies
The following is a law review interview with Professor Srividhya Ragavan on the issues in interpretation of data exclusivity provisions under the TRIPS Agreement, and the impact of data exclusivity on generic drugs.
The Significance of the Data Exclusivity and Its Impact on Generic Drugs,
J. Intell. Prop. Stud.
Available at: http://scholarship.law.tamu.edu/facscholar/816